# Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy

> **NCT01893788** · PHASE4 · UNKNOWN · sponsor: **Nagoya University** · enrollment: 100 (estimated)

## Conditions studied

- Hypertensive Left Ventricular Hypertrophy

## Interventions

- **DRUG:** Aliskiren
- **DRUG:** Eplerenone

## Key facts

- **NCT ID:** NCT01893788
- **Lead sponsor:** Nagoya University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-04
- **Primary completion:** 2016-03
- **Final completion:** —
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2013-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01893788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01893788, "Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01893788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*